<HashMap><database>biostudies-literature</database><scores/><additional><omics_type>Unknown</omics_type><volume>13(1)</volume><submitter>Kaya S</submitter><pubmed_abstract>&lt;b>Objectives:&lt;/b> This research is purposed to synthesize the existing evidence on implant survival rates in patients with oral potentially malignant disorders (OPMD) and assess potential risk factors associated with peri-implant disease. &lt;b>Material and Methods:&lt;/b> A comprehensive search was performed across PubMed MEDLINE, Cochrane Library, and Web of Science. This review was conducted according to the PRISMA guidelines, including studies published between 2012 and 2023. &lt;b>Results:&lt;/b> The review of studies related to oral lichen planus (OLP) revealed an implant survival rate of 99.3% (50% to 100%) with a mean follow-up of 40.1 months. One retrospective study focused on patients with leukoplakia and erythroplakia, but did not provide data on implant survival; however, it reported the </pubmed_abstract><journal>Dentistry journal</journal><pagination>35</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC11763872</full_dataset_link><repository>biostudies-literature</repository><pubmed_title>The Effect of Oral Potentially Malignant Disorders (OPMD) on Dental Implants Survival-A Systematic Review.</pubmed_title><pmcid>PMC11763872</pmcid><pubmed_authors>Muller-Heupt LK</pubmed_authors><pubmed_authors>Walter C</pubmed_authors><pubmed_authors>Khamis A</pubmed_authors><pubmed_authors>Schiegnitz E</pubmed_authors><pubmed_authors>Al-Nawas B</pubmed_authors><pubmed_authors>Zimmer S</pubmed_authors><pubmed_authors>Kaya S</pubmed_authors><pubmed_authors>Cascant Ortolano L</pubmed_authors><pubmed_authors>Sagheb K</pubmed_authors></additional><is_claimable>false</is_claimable><name>The Effect of Oral Potentially Malignant Disorders (OPMD) on Dental Implants Survival-A Systematic Review.</name><description>&lt;b>Objectives:&lt;/b> This research is purposed to synthesize the existing evidence on implant survival rates in patients with oral potentially malignant disorders (OPMD) and assess potential risk factors associated with peri-implant disease. &lt;b>Material and Methods:&lt;/b> A comprehensive search was performed across PubMed MEDLINE, Cochrane Library, and Web of Science. This review was conducted according to the PRISMA guidelines, including studies published between 2012 and 2023. &lt;b>Results:&lt;/b> The review of studies related to oral lichen planus (OLP) revealed an implant survival rate of 99.3% (50% to 100%) with a mean follow-up of 40.1 months. One retrospective study focused on patients with leukoplakia and erythroplakia, but did not provide data on implant survival; however, it reported the </description><dates><release>2025-01-01T00:00:00Z</release><publication>2025 Jan</publication><modification>2025-04-03T23:23:51.377Z</modification><creation>2025-04-03T23:23:51.377Z</creation></dates><accession>S-EPMC11763872</accession><cross_references><pubmed>39851611</pubmed><doi>10.3390/dj13010035</doi></cross_references></HashMap>